Related references
Note: Only part of the references are listed.The adiponectin signalling pathway - A therapeutic target for the cardiac complications of type 2 diabetes?
Abhipree Sharma et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Panax notoginseng Saponin Protects Against Diabetic Cardiomyopathy Through Lipid Metabolism Modulation
Chenyang Zhang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)
Ginsenoside Rb1 Protects Against Diabetic Cardiomyopathy by Regulating the Adipocytokine Pathway
Chenyang Zhang et al.
JOURNAL OF INFLAMMATION RESEARCH (2022)
Pharmacological properties, molecular mechanisms and therapeutic potential of ginsenoside Rg3 as an antioxidant and anti-inflammatory agent
Jing Wang et al.
FRONTIERS IN PHARMACOLOGY (2022)
Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus
Kazufumi Nakamura et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Acute and repeated dose 26-week oral toxicity study of 20(S)-ginsenoside Rg3 in Kunming mice and Sprague-Dawley rats
Chunmei Li et al.
JOURNAL OF GINSENG RESEARCH (2020)
A 26-week 20(S)-ginsenoside Rg3 oral toxicity study in Beagle dogs
Yonglin Gao et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Relationship Between Ginsenoside Rg3 and Metabolic Syndrome
Hyunji Lee et al.
FRONTIERS IN PHARMACOLOGY (2020)
The Mitochondria: A Target of Polyphenols in the Treatment of Diabetic Cardiomyopathy
Humna Bhagani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway
Xiangxiang Liu et al.
CELL DEATH & DISEASE (2020)
Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy
Hanbing Liu et al.
PHARMACOLOGICAL RESEARCH (2020)
Multiple Levels of PGC-1α Dysregulation in Heart Failure
Shin-ichi Oka et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Diabetic cardiomyopathy - A comprehensive updated review
Ghulam Murtaza et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2019)
Diabetic Cardiomyopathy What Is It and Can It Be Fixed?
Wolfgang H. Dillmann
CIRCULATION RESEARCH (2019)
Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications
Michele Longo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome
C. Ronald Kahn et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Unlocking the Secrets of Mitochondria in the Cardiovascular System Path to a Cure in Heart Failure-A Report from the 2018 National Heart, Lung, and Blood Institute Workshop
Rong Tian et al.
CIRCULATION (2019)
Thiazolidinediones: the Forgotten Diabetes Medications
Harold E. Lebovitz
CURRENT DIABETES REPORTS (2019)
Ginsenoside Rg3 (Shenyi Capsule) Combined with Chemotherapy for Digestive System Cancer in China: A Meta-Analysis and Systematic Review
Linlin Pan et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses
Li Li et al.
PHYTOMEDICINE (2019)
Panax notoginseng for Inflammation-Related Chronic Diseases: A Review on the Modulations of Multiple Pathways
Yu Xu et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2018)
PGC-1: The Energetic Regulator in Cardiac Metabolism
Wencheng Di et al.
CURRENT ISSUES IN MOLECULAR BIOLOGY (2018)
Identification of certain Panax species to be potential substitutes for Panax notoginseng in hemostatic treatments
Bin Rui Yang et al.
PHARMACOLOGICAL RESEARCH (2018)
Combination of Berberine with Resveratrol Improves the Lipid-Lowering Efficacy
Xiaofei Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
Arunkumar E. Achari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Ginsenoside Rg3 ameliorated HFD-induced hepatic steatosis through downregulation of STAT5-PPARγ
Jin-Bong Lee et al.
JOURNAL OF ENDOCRINOLOGY (2017)
Adiponectin and Cardiovascular Disease: Mechanisms and New Therapeutic Approaches
G. Siasos et al.
CURRENT MEDICINAL CHEMISTRY (2012)
PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty
Janice V. Huang et al.
JOURNAL OF LIPID RESEARCH (2012)
Beneficial effects of PPAR-γ ligands in ischemia-reperfusion injury, inflammation and shock
M Abdelrahman et al.
CARDIOVASCULAR RESEARCH (2005)